DOW JONES27,081.36-879.44 -3.15%
S&P 5003,128.21-97.68 -3.03%
NASDAQ8,965.61-255.67 -2.77%

B of A Securities Maintains Neutral on Clovis Oncology, Raises Price Target to $10

B of A Securities maintains Clovis Oncology (NASDAQ:CLVS) with a Neutral and raises the price target from $7 to $10.

Benzinga · 01/23/2020 18:16

B of A Securities maintains Clovis Oncology (NASDAQ:CLVS) with a Neutral and raises the price target from $7 to $10.